Analytical Data
-
基因名
MYLPF
- Application
-
别名
Fast skeletal myosin light chain 2MLC2B
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96A32
-
表达区间
2-169aa
-
分子量
34.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYLPF (Myosin Light Chain Phosphatase) is a crucial enzyme involved in the regulation of actin-myosin interactions, playing a significant role in muscle contraction and cellular movement. Understanding the structure and function of MYLPF is vital, as dysregulation of this phosphatase is implicated in various cardiovascular diseases and muscle disorders. Recent studies have highlighted the importance of MYLPF in modulating cellular signaling pathways, particularly in the context of inflammation and cell migration. Research into MYLPF has gained momentum due to its potential therapeutic applications; for instance, targeting MYLPF activity could lead to new strategies for treating conditions such as hypertension and heart failure. Furthermore, the development of MYLPF recombinant proteins has opened avenues for in vitro studies and drug discovery, allowing researchers to dissect its regulatory mechanisms and discover small molecules that can modulate its activity. Investigating the expression patterns, post-translational modifications, and interaction networks of MYLPF is essential for developing a comprehensive understanding of its role in cellular physiology and pathophysiology. As the field progresses, elucidating the functional diversity of MYLPF across different cell types and conditions may provide novel insights into muscle biology and disease mechanisms, paving the way for innovative therapeutic approaches.
